GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 273 filers reported holding GLOBUS MED INC in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,709,647 | +24.9% | 24,962 | -2.2% | 0.01% | +22.2% |
| Q1 2024 | $1,368,786 | +0.9% | 25,518 | +0.2% | 0.01% | -10.0% |
| Q4 2023 | $1,356,497 | +15.0% | 25,455 | +7.1% | 0.01% | 0.0% |
| Q3 2023 | $1,179,982 | -48.7% | 23,766 | -38.5% | 0.01% | -44.4% |
| Q2 2023 | $2,299,733 | +88830.1% | 38,625 | +10.9% | 0.02% | -18.2% |
| Q4 2022 | $2,586 | -99.9% | 34,824 | +14.0% | 0.02% | +22.2% |
| Q3 2022 | $1,820,000 | +3.3% | 30,544 | -2.7% | 0.02% | -5.3% |
| Q2 2022 | $1,762,000 | -17.5% | 31,393 | +8.4% | 0.02% | -9.5% |
| Q1 2022 | $2,137,000 | +12.9% | 28,964 | +10.5% | 0.02% | +5.0% |
| Q4 2021 | $1,892,000 | -4.5% | 26,206 | +1.3% | 0.02% | -13.0% |
| Q3 2021 | $1,982,000 | -1.1% | 25,869 | +0.1% | 0.02% | +4.5% |
| Q2 2021 | $2,004,000 | +26.0% | 25,852 | +0.3% | 0.02% | +10.0% |
| Q1 2021 | $1,590,000 | -4.3% | 25,783 | +1.3% | 0.02% | -13.0% |
| Q4 2020 | $1,661,000 | +38.9% | 25,460 | +5.5% | 0.02% | 0.0% |
| Q3 2020 | $1,196,000 | +56.5% | 24,143 | +50.8% | 0.02% | +64.3% |
| Q2 2020 | $764,000 | -0.8% | 16,007 | -11.6% | 0.01% | -22.2% |
| Q1 2020 | $770,000 | -3.6% | 18,109 | +33.4% | 0.02% | +28.6% |
| Q4 2019 | $799,000 | +15.8% | 13,577 | +0.6% | 0.01% | +16.7% |
| Q3 2019 | $690,000 | +20.8% | 13,495 | +0.0% | 0.01% | +20.0% |
| Q2 2019 | $571,000 | -13.9% | 13,490 | +0.6% | 0.01% | -16.7% |
| Q1 2019 | $663,000 | +14.9% | 13,414 | +0.6% | 0.01% | +9.1% |
| Q4 2018 | $577,000 | -31.7% | 13,340 | -10.4% | 0.01% | -8.3% |
| Q3 2018 | $845,000 | -15.3% | 14,890 | -24.7% | 0.01% | -7.7% |
| Q2 2018 | $998,000 | +2.5% | 19,782 | +1.2% | 0.01% | -7.1% |
| Q1 2018 | $974,000 | +123.9% | 19,545 | +84.6% | 0.01% | +133.3% |
| Q4 2017 | $435,000 | +39.0% | 10,588 | +0.5% | 0.01% | +20.0% |
| Q3 2017 | $313,000 | -10.3% | 10,533 | -0.0% | 0.01% | 0.0% |
| Q2 2017 | $349,000 | +12.2% | 10,538 | +0.3% | 0.01% | 0.0% |
| Q1 2017 | $311,000 | +17.8% | 10,507 | -1.3% | 0.01% | 0.0% |
| Q4 2016 | $264,000 | -72.0% | 10,649 | -73.0% | 0.01% | -64.3% |
| Q2 2014 | $943,000 | +2.2% | 39,405 | +13.5% | 0.01% | 0.0% |
| Q1 2014 | $923,000 | – | 34,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,860,000 | $41,980,000 | 4.04% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,010,575 | $22,808,000 | 2.39% |
| Van Berkom & Associates Inc. | 2,187,650 | $49,375,000 | 2.10% |
| Godshalk Welsh Capital Management, Inc. | 78,644 | $1,775,000 | 1.83% |
| Lloyds Banking Group plc | 8,462 | $190,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 2,360,955 | $53,287,000 | 1.38% |
| Copper Rock Capital Partners, LLC | 769,343 | $17,195,000 | 1.12% |
| FALCON POINT CAPITAL, LLC | 322,165 | $7,130,000 | 1.09% |
| KALMAR INVESTMENTS INC /DE/ | 1,037,337 | $23,413,000 | 1.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 864,719 | $19,517,000 | 1.02% |